Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

James A. Page, M.D.

Investigator Role:

Study Chair

Investigator Affiliation:

Oakwood Laboratories, LLC

Authority:

United States: Food and Drug Administration

Study ID:

OL-007

NCT ID:

NCT00076531

Start Date:

December 2003

Completion Date:

Related Keywords:

• Prostate Cancer
• Prostate
• Cancer
• PSA
• Leuprolide
• Prostatic Neoplasms

Name	Location